Hemenway Trust Hemenway Trust’s Ionis Pharmaceuticals IONS Stock Holding History

Hemenway Trust Hemenway Trust’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-9,705	Closed	-$464K	–	141
2016 Q4	$464K	Buy	9,705 +2,425	+33%	+$96K	0.12%	87
2016 Q3	$267K	Buy	+7,280	New	+$228K	0.07%	106
2016 Q2	–	Sell	-36,240	Closed	-$1.47M	–	122
2016 Q1	$1.47M	Buy	36,240 +20	+0.1%	+$812	0.4%	53
2015 Q4	$2.24M	Sell	36,220 -265	-0.7%	-$14.3K	0.59%	48
2015 Q3	$1.48M	Buy	36,485 +1,300	+4%	+$67.3K	0.41%	55
2015 Q2	$2.02M	Buy	35,185 +500	+1%	+$31.8K	0.52%	51
2015 Q1	$2.21M	Sell	34,685 -450	-1%	-$30.5K	0.58%	50
2014 Q4	$2.17M	Buy	35,135 +250	+0.7%	+$12.3K	0.65%	48
2014 Q3	$1.35M	Buy	34,885 +8,740	+33%	+$310K	0.42%	52
2014 Q2	$901K	Buy	+26,145	New	+$823K	0.27%	65

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Hemenway Trust Hemenway Trust's IONS Position: Q1 2017 in Review

Hemenway Trust Hemenway Trust sold out of Ionis Pharmaceuticals (IONS) in Q1 2017, closing a stake of 9,705 shares — an estimated $464K sold.

Hemenway Trust Hemenway Trust first reported a position in IONS in Q2 2014 and held it in 10 quarters. The position peaked at $2.24M in Q4 2015. 270 funds tracked by Wall St. Rank hold IONS as of Q1 2017.

Hemenway Trust Hemenway Trust reported no remaining Ionis Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
Hemenway Trust Hemenway Trust sold 9,705 Ionis Pharmaceuticals shares in Q1 2017, an estimated $464K.
Hemenway Trust Hemenway Trust first reported a position in Ionis Pharmaceuticals in Q2 2014 and held it in 10 quarters.
Hemenway Trust Hemenway Trust's Ionis Pharmaceuticals position peaked at $2.24M in Q4 2015.
270 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2017.

Based on Hemenway Trust Hemenway Trust's 13F filing for Q1 2017, filed 15 May 2017.